← TRINITY BIOTECH PLC TRIB
Market Price
$12.00
Market Cap
$8.10M
P/E Ratio
N/A
Revenue (FY 2025)
↓-29.0% YoY
$43.78M
3-Yr CAGR: -16.3%
Net Income
↓-17.6% YoY
-$37.38M
Net Margin: -85.4%
Free Cash Flow
↑76.3% YoY
-$96.00K
FCF Yield: -1.19%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
-35.5%
ROA: -35.5%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TRIB)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $99.6M | — | $43.5M | $-100.6M | — | — | — | $0.9M | — | — |
| FY 2017 | $99.1M | -0.5% | $41.9M | $-40.3M | +60.0% | — | — | $0.8M | $-4.1M | — |
| FY 2018 | $97.0M | -2.1% | $41.4M | $-22.1M | +45.1% | — | — | $0.9M | $-6.7M | -63.8% |
| FY 2019 | $90.4M | -6.8% | $38.1M | $-28.9M | -30.9% | — | — | $0.6M | $-1.6M | +76.6% |
| FY 2020 | $102.0M | +12.8% | $48.6M | $-6.4M | +77.9% | — | — | $0.1M | $-3.1M | -97.3% |
| FY 2021 | $93.0M | -8.8% | $38.1M | $0.9M | +113.7% | — | — | $0.0M | $-1.8M | +41.1% |
| FY 2022 | $74.8M | -19.6% | $22.0M | $-41.0M | -4,786.7% | — | — | $0.0M | $-1.1M | +39.3% |
| FY 2023 | $57.1M | -23.6% | $19.4M | $-24.0M | +41.4% | — | — | — | $-0.8M | +26.9% |
| FY 2024 | $61.6M | +7.9% | $21.4M | $-31.8M | -32.4% | — | — | — | $-0.4M | +49.6% |
| FY 2025 | $43.8M | -29.0% | $16.9M | $-37.4M | -17.6% | — | — | $-0.0M | $-0.1M | +76.3% |
Valuation
Market Price
$12.00
Market Cap
$8.10M
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
0.08
FCF Yield
-1.19%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
38.57%
Operating Margin
-85.82%
Net Margin
-85.36%
Return on Equity (ROE)
-35.54%
Return on Assets (ROA)
-35.54%
Asset Turnover
0.42x
Revenue 3-Yr CAGR
-16.34%
Financial Health & Liquidity
Current Ratio
1.00
Cash Ratio
0.14
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$5.14M
Total Debt
N/A
Book Value / Share
$155.79
Cash Flow Efficiency
Operating Cash Flow
-$8.00K
Capital Expenditures (CapEx)
$88.00K
Free Cash Flow
-$96.00K
OCF / Revenue
-0.02%
FCF / Revenue
-0.22%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$155.79
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$105.17M
Total Liabilities
$177.15M
Stockholders' Equity
$105.17M
Current Assets
$35.90M
Current Liabilities
$35.94M